Drug Trial News

RSS

Impact of prevention strategies and improvements in stroke healthcare

Coinciding with National Stroke Week in Australia (19 - 25 September 2005) is the release of results from two recent stroke studies from the George Institute for International Health that investigate both the causative factors as well as a little studied outcome of stroke, that of depression.

19 Sep 2005

MRC study to monitor Pentosan Polysulphate as a treatment for Creutzfeldt-Jakob disease receives approval

The plans for a monitoring study on patients being treated with Pentosan Polysulphate (PPS) for CJD and variant CJD have received a favourable opinion from the Eastern Multi-Centre Research Ethics Committee. This follows a provisional opinion from the committee in August.

19 Sep 2005

Does surgery induce angiogenesis in dormant breast cancer?

Analysis of breast-cancer relapse patterns from two independent databases provides indirect evidence for the theory that surgery to remove the primary tumor may initiate formation of a new blood supply (angiogenesis) in formerly dormant metastases, accounting for a pattern of early relapse in younger women.

12 Sep 2005

Retinoic acid combined with PIC, a synthetic immunity booster, significantly elevates the immune system response to a tetanus shot

These results show that a natural product of vitamin A can have an important role in regulating immunity and, when administered along with PIC, might be a potentially powerful nutritional-immunological assist in vaccination."

12 Sep 2005

New and unusual class of genes plays an important role in the development of chronic lymphocytic leukemia

The study found that the loss of two genes for producing small molecules known as microRNAs enables damaged cells to survive, rather than normally self-destructing before they become cancerous.

12 Sep 2005

Budesonide provides lasting relief for Crohn's disease patients

In a study published in The American Journal of Gastroenterology, researchers found that budesonide capsules are an effective treatment to prolong and maintain the period of remission of Crohn's Disease. Previous studies have demonstrated that budesonide is effective for inducing remission of Crohn's disease.

12 Sep 2005

Children who survive cancer face educational difficulties and social isolation

A new study finds children who survive cancer have about twice the rate of educational and social problems compared to children without a history of cancer.

12 Sep 2005

Number of women getting routine screening mammography may be less than previously reported

The study, published in the October 15, 2005 issue of CANCER, a peer-reviewed journal of the American Cancer Society, finds as many as one in three women have never had a mammogram or have not had one in more than two years, and that many women have one or two mammograms then fail to return for regular screenings.

12 Sep 2005

Large scale study to see if angioplasty can be safely performed in small hospitals

Cardiologists at Johns Hopkins have launched a nationwide study of more than 16,000 patients to see if a potentially life-saving procedure called angioplasty can be safely performed in smaller, community hospitals, easing access to the therapy for patients. Researchers expect to enroll the first study patients in early fall 2005.

12 Sep 2005

Amantadine resistant avian influenza viruses more common in Southeast Asia than North America

Resistance to the antiviral drug amantadine is spreading more rapidly among avian influenza viruses of H5N1 subtype in Southeast Asia than in North America, according to the study done by investigators at St. Jude Children's Research Hospital.

12 Sep 2005

Clioquinol appears to block the genetic action of Huntington's disease

Clioquinol, an antibiotic that was banned for internal use in the United States in 1971 but is still used in topical applications, appears to block the genetic action of Huntington's disease in mice and in cell culture, according to a study reported by San Francisco VA Medical Center (SFVAMC) researchers.

12 Sep 2005

Interpersonal and social rhythm therapy is helpful to many people with bipolar disorder

A treatment program that stresses maintaining a regular schedule of daily activities and stability in personal relationships is an effective therapy for bipolar disorder, report University of Pittsburgh School of Medicine researchers in September's Archives of General Psychiatry.

12 Sep 2005

Drug Trial News

Impact of prevention strategies and improvements in stroke healthcare

MRC study to monitor Pentosan Polysulphate as a treatment for Creutzfeldt-Jakob disease receives approval

Does surgery induce angiogenesis in dormant breast cancer?

Retinoic acid combined with PIC, a synthetic immunity booster, significantly elevates the immune system response to a tetanus shot

New and unusual class of genes plays an important role in the development of chronic lymphocytic leukemia

Budesonide provides lasting relief for Crohn's disease patients

Children who survive cancer face educational difficulties and social isolation

Number of women getting routine screening mammography may be less than previously reported

Large scale study to see if angioplasty can be safely performed in small hospitals

Amantadine resistant avian influenza viruses more common in Southeast Asia than North America

Clioquinol appears to block the genetic action of Huntington's disease

Interpersonal and social rhythm therapy is helpful to many people with bipolar disorder

Young adults have a greater ability to hold their tongue than older adults

United States investment in tuberculosis treatment abroad saves lives and money at home

Is suburban life making people overweight?

Low-fat, plant-based diet is more effective at helping women lose weight

Scientists characterize the most infectious prion protein particles

Smokers twice as likely to lose their sight - calls for warnings on cigarette packets

Depression may hasten the progression of heart disease

Bacteria lurking in household dust produce chemicals that may trigger asthma

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News